"Fiziotenz" - an antihypertensive agent for the treatment of hypertension.
The analogs of this drug are "Moksoniteks", "Moxonidine", "Cynthia."
All of them have the same active ingredient - moxonidine.
Indications "Fiziotenza" designation and its analogues
"Fiziotenz" The drug is produced inGerman pharmaceutical company Solvay Pharmaceuticals B.V. Its analogue "Moksoniteks" produced by German company Salutas Pharma. Its analogue "Cynthia" is made «Eli Lilly» company (USA). "Moxonidine" produces the Russian "Farmzaschita". These drugs are prescribed for the treatment of hypertension. All drugs have the same active ingredient - moxonidine.
Moxonidine stimulates the sensory receptors,participating in the management of the sympathetic nervous system, activation of these receptors decreases blood pressure. "Fiziotenz" or its analogues are administered in a dose of 200 micrograms per day, the maximum amount of product per day is 600 mg, the highest possible single dose - 400 micrograms. Take "Fiziotenz" or replace its analogues can be only after consultation with your doctor, self can be dangerous.
If the patient suffers from renal failure, the daily dose should be 200 mg.
Side effects, contraindications to preparations containing moxonidine
"Fiziotenz" and analogues on responses can causethe same side effects: Temporary disorders of the central nervous system (headache, dizziness, drowsiness), excessive pressure drop, tongue and mouth become dry. These drugs should not be taken during pregnancy and lactation. During treatment it is necessary to exclude the use of alcohol at the beginning of therapy is not recommended to work with machinery that requires quick response and attention.
"Fiziotenz" and analogues are contraindicated in age18, in case of hypersensitivity to the active component of the drug, when hereditary galactose intolerance, sick sinus syndrome with bradycardia (low heart rate). In the absence of clinical experience, the use of preparations containing moxonidine in patients with intermittent claudication, Raynaud's disease, depression, epilepsy, Parkinson's, glaucoma can be dangerous.
"Fiziotenz" and analogues with extreme caution should be taken in patients with renal insufficiency and patients who are on hemodialysis.
If medicines containingmoxonidine administered together with the drugs - beta-blockers, the effect of moxonidine on blood pressure increases. After the cancellation of "Fiziotenza" and unique due to the ongoing treatment of the beta-blocker has a risk of severe arterial hypertension. Therefore, in this case, we recommend that you cancel the beta-blocker, and a few days later with the drug Moxonidine. With the simultaneous use of these funds with the drugs, have a depressing effect on the central nervous system (sleeping pills, tranquilizers), deprimiruyuschee (overwhelming) influence on the central nervous system is enhanced.